Adult-Onset Still’s Disease and Secondary Hemophagocytic Lymphohistiocytosis: Diagnostic Pitfalls in Lymph Node Histology

Document Type : Case Reports

Authors

1 Department of Pathology, All India Institute of Medical Sciences, Nagpur, Plot-2, Sector-20, MIHAN, Nagpur, Maharashtra, India

2 Department of General Medicine, All India Institute of Medical Sciences, Nagpur, Plot-2, Sector-20, MIHAN, Nagpur, Maharashtra, India

10.30699/ijp.2026.2067545.3498
Abstract
Background & Objective: Adult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disorder characterized by high spiking fevers, evanescent rash, arthritis, and systemic inflammation. Its diagnosis is challenging due to the lack of specific biomarkers and clinical overlap with infections, malignancies, and autoimmune diseases.
Case Report: We present the case of a 20-year-old female with a two-year history of recurrent fever, polyarthritis, and erythematous rash, accompanied by generalized lymphadenopathy and splenomegaly. Initial workup revealed severe anemia, leukocytosis, markedly elevated serum ferritin, and abnormal liver function tests. Infectious and malignant etiologies were excluded. Lymph node biopsies initially suggested dermatopathic lymphadenitis, but subsequent histology showed paracortical hyperplasia with features mimicking peripheral T-cell lymphoma. Immunohistochemistry revealed a polyclonal T-cell population and hemophagocytosis, leading to a revised diagnosis of reactive lymphadenopathy associated with AOSD. The patient fulfilled criteria for secondary hemophagocytic lymphohistiocytosis (HLH), a life-threatening hyperinflammatory syndrome. High-dose corticosteroid therapy resulted in significant clinical and biochemical improvement.
Conclusion: This case highlights the diagnostic complexities of AOSD with secondary HLH, particularly when lymph node histology mimics malignancy. Awareness of the varied lymph node patterns in AOSD and integration of clinical, laboratory, and immunohistochemical data are crucial for accurate diagnosis and timely management, preventing unnecessary interventions and improving outcomes.

Keywords

Subjects


1.      Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still's disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum. 2021;51(4):858-74. [DOI:10.1016/j.semarthrit.2021.06.004] [PMID]
2.      Jeon YK, Paik JH, Park SS, Park SO, Kim YA, Kim JE, et al. Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol. 2004;57(10):1052-6. [PMID] [PMCID]      [DOI:10.1136/jcp.2004.018010]
3.      Soy M, Ergin M, Paydas S. Lymphadenopathy in adult-onset Still's disease mimicking peripheral T-cell lymphoma. Clin Rheumatol. 2004;23(1):81-2. [DOI:10.1007/s10067-003-0826-y] [PMID]
4.      Kim HA, Kim YH, Jeon YK, Yang WI, Kwon JE, Han JH. Histopathology and expression of the chemokines CXCL10, CXCL13, and CXCR3 and the endogenous TLR-4 ligand S100A8/A9 in lymph nodes of patients with adult-onset Still's disease. Sci Rep. 2019;9(1):7517. [DOI:10.1038/s41598-019-44032-6] [PMID] [PMCID]
5.      Paul M, Paul P, Dey D, Safdar S, Ramos J. Adult-onset Still's disease with extensive lymphadenopathy mimicking lymphoproliferative malignancy. Cureus. 2021;13(7):e16163. [DOI:10.7759/cureus.16163]
6.      Huang Z, Xu H, Min Q, Li Z, Bi J, Liu L, et al. Adult-onset Still's disease with multiple lymphadenopathy: a case report and literature review. Diagn Pathol. 2021;16(1):97. [DOI:10.1186/s13000-021-01159-3] [PMID] [PMCID]
7.      Lee SW, Park MC, Kim H, Park YB, Lee SK. Dermatopathic lymphadenopathy in a patient with adult onset Still's disease. Clin Exp Rheumatol. 2007;25(2):312-4.
8.      Donaire-Castaños JC, Demelo-Rodríguez P, Ordieres-Ortega L, Pardo-Sánchez S, Galeano-Valle F. Overlap of adult-onset Still disease and Kikuchi-Fujimoto disease: a case report and literature review. Cureus. 2024;16(11):e73283. [DOI:10.7759/cureus.73283] [PMID] [PMCID]
9.      Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020;34(4):101515. [DOI:10.1016/j.berh.2020.101515] [PMID]
10.   Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-31. [DOI:10.1002/pbc.21039] [PMID]

Articles in Press, Accepted Manuscript
Available Online from 25 February 2026

  • Receive Date 31 July 2025
  • Revise Date 29 September 2025
  • Accept Date 21 January 2026